-
Signature
-
/s/ Ian A. Johnston, Attorney-in-Fact for Rohit Ramchandani
-
Issuer symbol
-
PHLT
-
Transactions as of
-
07 Sep 2023
-
Net transactions value
-
-$32,246
-
Form type
-
4
-
Filing time
-
11 Sep 2023, 19:28:40 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Options Exercise |
$0 |
+15,525 |
+11% |
$0.000000 |
160,092 |
07 Sep 2023 |
Direct |
|
| transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Tax liability |
$12,939 |
-5,369 |
-3.4% |
$2.41 |
154,723 |
07 Sep 2023 |
Direct |
F1 |
| transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Options Exercise |
$0 |
+23,164 |
+15% |
$0.000000 |
177,887 |
07 Sep 2023 |
Direct |
|
| transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Tax liability |
$19,307 |
-8,011 |
-4.5% |
$2.41 |
169,876 |
07 Sep 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PFMT |
Restricted Stock Units |
Options Exercise |
|
-15,525 |
-33% |
|
31,050 |
07 Sep 2023 |
Common Stock |
15,525 |
$0.000000 |
Direct |
F2, F3 |
| transaction |
PFMT |
Restricted Stock Units |
Options Exercise |
|
-23,164 |
-25% |
|
69,486 |
07 Sep 2023 |
Common Stock |
23,164 |
$0.000000 |
Direct |
F2, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: